Sleep Quality & Psoriatic Arthritis
For people living with psoriatic arthritis (PsA), the comfort of a good night's sleep may feel out of reach for many.
Read more →What's hot
View all perspectives
What's Hot
Ultrasound in PsA
Dr. Arthur Kavanaugh discusses abstract 2206 presented at ACR22 in Philadelphia. Abstract 2206: Understanding Inter-rater Variability in Scoring of Entheseal Lesions: Results from the Diagnostic Ultrasound Enthesitis Tool (DUET) Study
Watch video →
Tapering TNFi in nonradiographic AxSpA
Dr. Peter Nash at ACR22 Convergence in Philadelphia, PA.
Watch video →
Sunday (Day 2): ACR 22 Daily Recap
ACR 2022 Daily Recap for Sunday, November 13th. Panelists: Drs. Robert Chao, Antoni Chan, Bella Mehta, Janet Pope, Yuz Yusof, Cassy Sims, Akhil Sood, Sheila Reyes and Jack Cush.
Watch video →
Spondyloarthritis: Novel Therapies, Diagnostic Dilemmas and Depression
Dr. Lianne Gensler discusses the following abstracts presented at ACR22 Convergence. Abstracts 1597, 1598, 1599 (treatment) and 1613, 1609 and 1614 (diagnosis and outcomes)
Watch video →
Deucravacitinib in PsA
Dr. Arthur Kavanaugh discusses abstract 1598 at ACR22 Convergence in Philadelphia. Abstract 1598: Safety and Efficacy of Deucravacitinib, an Oral, Selective Tyrosine Kinase 2 Inhibitor, in Patients with Psoriatic Arthritis: 52-Week Results from a Randomized Phase 2 Trial
Watch video →
Sarilumab in Polymyalgia Rheumatica: Results from SAPHYR Trial
Dr. Michael Putman interviews Dr. Robert Speira about abstract 1676 presented at the ACR22 Convergence meeting in Philadelphia, PA. Abstract 1676: Sarilumab in Patients with Relapsing Polymyalgia Rheumatica: A Phase 3, Multicenter, Randomized, Double Blind, Placebo Controlled Trial (SAPHYR)
Watch video →
PET CT Imaging to Define Risk of Progression from PSO to PsA
Dr. Peter Nash discusses Abstract 1018 at ACR22 Convergence.
Watch video →
ACR22 Daily Recap: Saturday Recap
Panelists: Drs. Jack Cush, Michael Putman, Eric Dein, Patricia Harkins and Rachel Tate.
Watch video →
Robert B Chao, MD doctorRBC
3 years 1 month ago
Very complex conversation on why opioids are used...
Opioid use in patients with PsA and AS led to higher healthcare utilization and higher costs.
Opioid users - more co-morbidities, smokers, worse disease activity
Opioid users spent more on drug costs
Abs#0402 @RheumNow #ACR22 https://t.co/dbUPg5LGLy
Richard Conway RichardPAConway
3 years 1 month ago
Rathmann et al. Incidence/Prevalence AAV in Sweden over time. Incidence stable. Prevalence increasing and higher in men. Incidence increases with age and commonest 70-84 years @rheumnow #ACR22 Abstr#0451 https://t.co/yCMOC7dAvq https://t.co/y0tqkaV8zX
Md Yuzaiful Md Yusof Yuz6Yusof
3 years 1 month ago
#ACR22 Abstr#2081 What is the nature of breakthrough #COVID infection in #lupus patients in Omicron era? A cohort study in New York showed those receiving booster vac were less likely to develop infection vs receiving 2 vaccine doses. Only 2 hospitalised, no deaths @RheumNow https://t.co/6UaTMN5Dev
Richard Conway RichardPAConway
3 years 1 month ago
Rooney et al. Seasonality of GCA in UK and Ireland - DCVAS/TABUL/local hospital combined dataset. 2 peaks - spring/early summer every year, and a second peak most years in autumn or winter. @rheumnow #ACR22 Abstr#0495 https://t.co/Trz8ou9xGh https://t.co/jcS3Z30nz8
Janet Pope Janetbirdope
3 years 1 month ago
Do you see #JAKis causing weight gain? 429 Pts BUT during #COVID19 - 68% gained wt in RA 1.5 Kg mean; and more in SpA 71% w 2.6 Kg. Was it Rx or COVID related? #ACR22 abst0291 @RheumNow
Richard Conway RichardPAConway
3 years 1 month ago
Ruiz et al. bDMARD/tsDMARD use in RA after breast cancer. Low use, 15.5% on bDMARD, 1.5% on tsDMARD. Stable use over last 10 years @rheumnow #ACR22 Abstr#0080 https://t.co/0L6uuVtQQw https://t.co/xBH1bUdeSD
Bella Mehta bella_mehta
3 years 1 month ago
#disparities study using admin data
- 580 pts with incidence childhood #SLE with LN
- LN codes before SLE codes - more likely publicly insured, rural area, Hispanic ethnicity, kidney transplant
- differential access!!
@RADoctor @rheumnow #ACR22 abst#0068 https://t.co/uryCZq94dX
Dr. Rachel Tate uptoTate
3 years 1 month ago
Early Izokibep (IL17Ai) data demonstrated clinically meaningful, dose-dependent improvement across PROs, particularly sleep, pain, function ,+ SF36 and PsAID subdomains in PsA pts. Pts w/ baseline enthesitis had greater benefit. Abs 0199 #ACR22 @RheumNow https://t.co/sXVdwGPVnd https://t.co/Cxyfp6OXOY
TheDaoIndex KDAO2011
3 years 1 month ago
Did you get the updated #COVIDbooster before you arrived at #ACR22? Answers are anonymous @rheumnow
Robert B Chao, MD doctorRBC
3 years 1 month ago
Use of AI to detect sacroilitis in axSpA and nr-axSpA.
Pre-trained AI neural network can detect sacroilitis, especially new data, similar to human radiology experts.
Abs#0383 @RheumNow #ACR22 https://t.co/5hdrKxT3HP
Patricia Harkins DrTrishHarkins
3 years 1 month ago
‼️Frailty in Vasculitis‼️
👉VascStrong using VPPRN
✏️ FRAIL scale
👉 n=328
🌟21.6% frail
🌟42.1% pre frail
💥 frailty assoc ⬆️ pain, fatigue and ⬇️ mood and fn
💥⬆️ wt and females higher frailty
Abst0444
#ACR22 #GeriRheum @RheumNow @SattuiSEMD
Janet Pope Janetbirdope
3 years 1 month ago
Elderly onset #rheumatoid #arthritis does worse than younger people. Data from Japan - Benefit is less and side effects more. Less remission and worse HAQ scores. ?due to RA differences or changes due to age or both or neither? #ACR22 abst0244 @RheumNow @ACRheum https://t.co/FqvLA765Cu
Richard Conway RichardPAConway
3 years 1 month ago
Remuzgo-Martinez et al. Serum endothelin-1 in CTD-ILD. Significantly higher levels than healthy controls. No difference between CTD-ILD and IPF. @rheumnow #ACR22 Abstr#0123 https://t.co/Jf3AumSnjt https://t.co/Xki8LEEcnV
Richard Conway RichardPAConway
3 years 1 month ago
de Boysson et al. Beta-blockers may prevent aortic dilation in LVV GCA (0% vs 23%). 65 patients, retrospective , and patients were on beta-blockers for other reasons, but thought-provoking @rheumnow #ACR22 Abstr#0477 https://t.co/AVmIwCk3LV https://t.co/Plv5tcN5mR
Poster Hall